TP53 and cancer: Previous studies confirmed that p53 mutation occurs in 96% of high-grade serous ovarian cancers and mutations in p53 and Kras promote ovarian cancer by transforming primary tubal epithelial cells into cancer cells in mice (Tarangelo et al., 2018).